SG Americas Securities LLC Acquires 35,823 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

SG Americas Securities LLC increased its position in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 65.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 90,355 shares of the company's stock after acquiring an additional 35,823 shares during the quarter. SG Americas Securities LLC's holdings in LifeStance Health Group were worth $666,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of LFST. JPMorgan Chase & Co. boosted its position in shares of LifeStance Health Group by 13.0% in the third quarter. JPMorgan Chase & Co. now owns 94,636 shares of the company's stock valued at $662,000 after acquiring an additional 10,894 shares during the period. Principal Financial Group Inc. grew its position in LifeStance Health Group by 6.1% in the 3rd quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company's stock worth $28,817,000 after purchasing an additional 235,316 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of LifeStance Health Group by 26.8% during the 3rd quarter. Geode Capital Management LLC now owns 3,452,178 shares of the company's stock worth $24,170,000 after purchasing an additional 729,794 shares during the period. Wellington Management Group LLP raised its position in shares of LifeStance Health Group by 15.2% during the third quarter. Wellington Management Group LLP now owns 4,830,441 shares of the company's stock valued at $33,813,000 after buying an additional 638,385 shares during the last quarter. Finally, State Street Corp lifted its stake in shares of LifeStance Health Group by 4.7% in the third quarter. State Street Corp now owns 2,750,656 shares of the company's stock valued at $19,255,000 after buying an additional 122,844 shares during the period. Institutional investors and hedge funds own 85.50% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on LFST. Barclays lifted their price objective on LifeStance Health Group from $6.00 to $7.00 and gave the company an "underweight" rating in a report on Monday, November 11th. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 price target on the stock in a research report on Monday, December 16th. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $8.70.

Insider Activity

In other LifeStance Health Group news, Director Robert Bessler sold 75,000 shares of the company's stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $7.54, for a total transaction of $565,500.00. Following the completion of the transaction, the director now owns 1,424,447 shares of the company's stock, valued at $10,740,330.38. This represents a 5.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 6.60% of the company's stock.

LifeStance Health Group Trading Up 1.4 %

Shares of NASDAQ:LFST traded up $0.12 during mid-day trading on Monday, reaching $8.09. The stock had a trading volume of 369,367 shares, compared to its average volume of 1,040,267. The firm has a 50 day simple moving average of $7.59 and a two-hundred day simple moving average of $6.92. LifeStance Health Group, Inc. has a twelve month low of $4.64 and a twelve month high of $9.20. The firm has a market cap of $3.09 billion, a PE ratio of -31.17 and a beta of 1.28. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.02) EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.05. The business had revenue of $312.70 million during the quarter, compared to analysts' expectations of $302.25 million. LifeStance Health Group had a negative net margin of 7.90% and a negative return on equity of 6.66%. The firm's quarterly revenue was up 18.9% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.17) EPS. On average, research analysts predict that LifeStance Health Group, Inc. will post -0.18 EPS for the current fiscal year.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.